Biochemical, hormonal and genetic evaluation of the families of two Brazilian patients with type 2 familial partial lipodystrophy
CONCLUSION: A mutation in the LMNA gene is a determinant of clinical, biochemical and hormonal changes that imply in metabolic deterioration in mutation carriers.
Source: Arquivos Brasileiros de Endocrinologia e Metabologia - Category: Endocrinology Source Type: research
More News: Diabetes | Diabetes Type 2 | Endocrinology | Genetics | Hormones | Insulin | Men | Polycystic Ovary Syndrome